Professor Choudhury is Chair and Honorary Consultant in Clinical Oncology. She joined The Christie in 2008 specialising in urology and sarcoma and has a strong interest in translational research. In 2013, she decided to focus on radiotherapy-related research in prostate and bladder cancers. Her current research aims to optimise and personalise radiotherapy using new techniques or imaging technology to deliver high doses of radiotherapy while minimising side-effects, and predictive biomarkers to determine which patients benefit from different treatments. Within the Division of Cancer Sciences, The University of Manchester, she is clinical lead for advanced radiotherapy, including the MRLinac project, and is co-Group Leader of The Translational Radiobiology Group.
Professor Choudhury graduated from Trinity College, Cambridge, but undertook her Clinical Oncology training at the Yorkshire Deanery from 2000-2008. Between 2005 and 2007, she was a Cancer Research UK Clinical Training Research Fellow and she undertook her PhD at the University of Leeds and Princess Margaret Hospital in Toronto, Canada. She has a lead role in education and training for specialist registrars and clinical fellows.
Over the past few years, Professor Choudhury has been involved with national concerns such as the Royal College of Radiologists, the National Cancer Research Institute (NCRI) Clinical and Translational Radiotherapy Research Working Group (CTRad), the NCRI Bladder Clinical Studies Group and the National Institute of Health and Care Excellence (NICE). Professor Choudhury was Senior Editor for genito-urinary cancers for the International Journal of Radiation Oncology • Biology • Physics (The Red Journal). Since early 2021, she has been the Editor in Chief of Clinical Oncology.
